When investing in stock markets, it’s crucial to make a distinction between high-quality and poor-quality businesses across the small-, mid...

Indian drug regulators have mandated cautionary labels for nimesulide, restricting its use as a second-line treatment for patients 12 years...

The Indian Council of Medical Research (ICMR) has recommended a ban on Nimesulide for individuals under 18 and over 60 due to safety concer...

Between 2005 to 2015, the pharma sector was one of the best performing sectors with stocks creating big wealth for the shareholders. Then c...

If one looks at corporate announcements, a large number of small and mid-caps pharma companies are announcing one or the other thing either...

There are some sectors which are able to face bears in a better way. The reason, the operating matrix of those sectors is such that rising ...

Both, in terms of bottomline and stock price performance, pharma stocks had been under pressure for a long time. Partly this under performa...

Minister of State for Health Faggan Singh Kulaste in a written reply said that the drugs which have been allowed are nimesulide, analgin an...

Early this year, the health ministry had banned sale of anti-inflammatory drug nimesulide for use in children below 12 years of age.

The government has decided to frame guidelines on advertisements of emergency contraceptive pills (ECP) to ensure consumers be aware of the...

The proposed trade margin cut on generic drugs from October 2 is set to be applicable to 2,000 brands of specified strengths, and as a resu...

Prices of commonly used medicines such as paracetamol, nimesulide, cetrizine and omeprazole are set to come down sharply.